ConductScience.org, home

Paper19468024

Reversal of neuromuscular block.

Srivastava A and 1 other. Br J Anaesth, 2009. Cited by 118 papers, by iCite.

Cite this record

ConductScience Library. Reversal of neuromuscular block. Papers, record 19468024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19468024

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reversal of neuromuscular block.
PubMed
Journal
Br J Anaesth
PubMed
Year
2009
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
118
iCite
Relative citation ratio, by iCite
5.05
iCite
Revised in PubMed
2022-03-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Srivastava AA
2Hunter JMJ M

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cholinesterase InhibitorsMajor topic
CyclodextrinsMajor topic
Neuromuscular BlockadeMajor topic
Neuromuscular Blocking AgentsMajor topic
Neuromuscular JunctionMajor topic
Anesthesia Recovery Period
Animals
Clinical Trials as Topic
Humans
Postoperative Complications
Sugammadex
gamma-Cyclodextrins

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01690338A Study of Residual Curarization Incidence in ChinaBackgroundClinicalTrials.gov
NCT04236050Continuous Infusion and Bolus Doses of Rocuronium During Lumbal Discectomy, Muscle Strength and Patient RecoveryResultsClinicalTrials.gov

Download CSV of trials

Cited by56

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.

PMIDTitleJournalYearIn PapersSource
42889689Comparison of Sugammadex and Neostigmine for Reversal of Vecuronium-Induced Neuromuscular Blockade in Pediatric Patients: A Prospective Randomized Study.Cureus2026https://conductscience.org/library/papers/42889689PubMed
42750962Clinical application of sugammadex in renal impairment: pharmacokinetics and pharmacodynamics.Front Pharmacol2026https://conductscience.org/library/papers/42750962PubMed
42739675Impact of Sugammadex on Clinical and Patient-Centered Outcomes: Beyond Neuromuscular Recovery.J Clin Med2026https://conductscience.org/library/papers/42739675PubMed
42317954The Effect of Sugammadex Versus Neostigmine on Postoperative Cognitive Recovery: A Systematic Review and Meta-Analysis.Cureus2026https://conductscience.org/library/papers/42317954PubMed
42306367Recurarization in the Post-anesthesia Care Unit One Hour After Sugammadex Administration: A Case Report.Cureus2026https://conductscience.org/library/papers/42306367PubMed
42226831Sugammadex Versus Neostigmine: A Comparative Study of Efficacy and Safety in the Cath Lab.Cureus2026https://conductscience.org/library/papers/42226831PubMed
42135214Current recommendations for preventing residual neuromuscular blockade.Anesth Pain Med (Seoul)2026https://conductscience.org/library/papers/42135214PubMed
41913738Low-Dose Neostigmine at 0.7 Train-of-Four Ratio Safely Accelerates Neuromuscular Recovery: A Prospective Observational Study.Drug Des Devel Ther2026https://conductscience.org/library/papers/41913738PubMed
41629787Sugammadex and intraocular pressure: systematic review with meta-analysis and trial sequential analysis.BMC Anesthesiol2026https://conductscience.org/library/papers/41629787PubMed
41175280Association Between Sugammadex Use and Risk of Postoperative Urinary Complications after Metabolic and Bariatric Surgery: A Multi-Institutional Study.Obes Surg2025https://conductscience.org/library/papers/41175280PubMed
41096426Sugammadex and Acceleromyography Used During a Lensectomy in a Sea Lion (Zalophus californianus).Animals (Basel)2025https://conductscience.org/library/papers/41096426PubMed
41071214Effects of sugammadex on the incidence of postoperative nausea and vomiting in patients undergoing laparoscopic abdominal surgery: a randomized controlled study.Surg Endosc2026https://conductscience.org/library/papers/41071214PubMed
39118951Eliminating residual neuromuscular blockade: a literature review.Ann Transl Med2024https://conductscience.org/library/papers/39118951PubMed
36829738Ιnclusion Complexes of Magnesium Phthalocyanine with Cyclodextrins as Potential Photosensitizing Agents.Bioengineering (Basel)2023https://conductscience.org/library/papers/36829738PubMed
36569123Sugammadex versus neostigmine for neuromuscular blockade reversal in outpatient surgeries: A randomized controlled trial to evaluate efficacy and associated healthcare cost in an academic center.Front Med (Lausanne)2022https://conductscience.org/library/papers/36569123PubMed
36561110Perioperative Efficiency of Sugammadex Following Laparoscopic Cholecystectomy in Clinical Practice.Ochsner J2022https://conductscience.org/library/papers/36561110PubMed
36561101Hawthorne Effect: More Than Just Telephones.Ochsner J2022https://conductscience.org/library/papers/36561101PubMed
36064986Effect of neuromuscular reversal with neostigmine/glycopyrrolate versus sugammadex on postoperative ileus following colorectal surgery.Tech Coloproctol2023https://conductscience.org/library/papers/36064986PubMed
35925158[Anesthesia for thoracic surgery in a female patient with Ullrich congenital muscular dystrophy].Anaesthesiologie2022https://conductscience.org/library/papers/35925158PubMed
35737717Modeling cortical synaptic effects of anesthesia and their cholinergic reversal.PLoS Comput Biol2022https://conductscience.org/library/papers/35737717PubMed

See all 56 cited byDownload CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
ROCURONIUMCHEMBL1201244Results1https://conductscience.org/library/drugs/CHEMBL1201244

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19468024

GET https://conductscience.org/api/papers/v1/19468024/cited_by?page=2